PA8388101A1 - Tableta de liberacion controlada. - Google Patents

Tableta de liberacion controlada.

Info

Publication number
PA8388101A1
PA8388101A1 PA19968388101A PA8388101A PA8388101A1 PA 8388101 A1 PA8388101 A1 PA 8388101A1 PA 19968388101 A PA19968388101 A PA 19968388101A PA 8388101 A PA8388101 A PA 8388101A PA 8388101 A1 PA8388101 A1 PA 8388101A1
Authority
PA
Panama
Prior art keywords
polymer
excipient
controlled release
release tablet
lubricant
Prior art date
Application number
PA19968388101A
Other languages
English (en)
Inventor
Cherng-Ju Kim
Original Assignee
Univ Temple
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Temple filed Critical Univ Temple
Publication of PA8388101A1 publication Critical patent/PA8388101A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)

Abstract

EL PRESENTE INVENTO PROPORSIONA UNA TABLETA DE LIBERACION CONTROLADA QUE INCLUYE UN AGENTE QUE INCLUYE UN AGENTE FARMACEUTICO Y UN EXCIPIENTE. EL EXCIPIENTE INCLUYE POR LO MENOS CERCA DE 50% DE UN POLIMERO HIDRAULICO Y UN LUBRICANTE. EL POLIMERO HIDRAULICO ES ESCOGIDO DE MANERA TAL QUE LA TASA DE DELATACION DEL POLIMERO SEA IGUAL IGUAL A LA TASA DE DISOLUCION DEL POLIMERO DILATADO. EL LUBRICANTE POR LO GENERAL ESTA PRESENTE EN UNA CANTIDAD HASTA DE 3% DEL EXCIPIENTE COMO UN TODO. EL EXCIPIENTE TAMBIEN PUEDE INCLUIR AQUELLOS OTROS INGRDIENTES TALES COMO DILUYENTES, SUSTANCIAS DE RELLENO, AGLUTINANTES Y DEMAS COMPUESTOS INACTIVOS FARMACOLOGICAMENTE. ADEMAS, EL POLIMERO Y EL AGENTE FARMACEUTICO SON COMPLEMENTARIOS.
PA19968388101A 1995-02-28 1996-11-08 Tableta de liberacion controlada. PA8388101A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39579295A 1995-02-28 1995-02-28

Publications (1)

Publication Number Publication Date
PA8388101A1 true PA8388101A1 (es) 1997-09-30

Family

ID=23564527

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19968388101A PA8388101A1 (es) 1995-02-28 1996-11-08 Tableta de liberacion controlada.

Country Status (11)

Country Link
EP (1) EP0821582B1 (es)
JP (1) JPH11509169A (es)
AR (1) AR003928A1 (es)
AT (1) ATE228829T1 (es)
AU (1) AU722741B2 (es)
CA (1) CA2213455A1 (es)
DE (1) DE69625189D1 (es)
MY (1) MY113429A (es)
PA (1) PA8388101A1 (es)
TW (1) TW431891B (es)
WO (1) WO1996026718A2 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945125A (en) * 1995-02-28 1999-08-31 Temple University Controlled release tablet
EP0951278A2 (en) * 1997-01-03 1999-10-27 ELAN CORPORATION, Plc Sustained release cisapride mini-tablet formulation
US6090411A (en) * 1998-03-09 2000-07-18 Temple University Monolithic tablet for controlled drug release
CA2396782A1 (en) 2000-02-04 2001-08-09 Depomed, Inc. Shell-and-core dosage form approaching zero-order drug release
US7612112B2 (en) 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
US6723340B2 (en) * 2001-10-25 2004-04-20 Depomed, Inc. Optimal polymer mixtures for gastric retentive tablets
TWI312285B (en) 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
EP1558081A4 (en) 2003-01-13 2006-06-14 Dynogen Pharmaceuticals Inc METHOD OF TREATING FUNCTIONAL INTESTINAL DISORDERS
US20050013863A1 (en) 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
MXPA06014587A (es) 2004-06-17 2007-04-27 Forest Laboratories Formulaciones de liberacion modificada de formulaciones de dosificacion oral de memantina.
EP1954257A4 (en) 2005-10-14 2009-05-20 Lundbeck & Co As H METHOD FOR TREATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM WITH A LOW-DOSED COMBINATION OF ESCITALOPRAM AND BUPROPION
US20090176882A1 (en) 2008-12-09 2009-07-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
US20070202164A1 (en) * 2006-02-28 2007-08-30 Hutchison Medipharma Enterprises Limited Andrographis Extract Formulations
WO2010026467A2 (en) 2008-09-04 2010-03-11 Torrent Pharmaceuticals Ltd. Controlled release dosage form of high solubility active ingredient
WO2010123930A2 (en) 2009-04-20 2010-10-28 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
US9901551B2 (en) 2009-04-20 2018-02-27 Ambra Bioscience Llc Chemosensory receptor ligand-based therapies
US8828953B2 (en) 2009-04-20 2014-09-09 NaZura BioHealth, Inc. Chemosensory receptor ligand-based therapies
MX2013004364A (es) 2010-10-19 2013-07-02 Elcelyx Therapeutics Inc Terapias a base de ligando del receptor quimiosensorial.
MX2013007884A (es) 2011-01-07 2013-09-13 Elcelyx Therapeutics Inc Terapias a base de ligando del receptor quimiosensorial.
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2013158928A2 (en) 2012-04-18 2013-10-24 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
JP2016520653A (ja) 2013-06-05 2016-07-14 シンクロニューロン インコーポレイテッド アカンプロサート製剤、それを用いる方法、およびそれを含む合剤
US9617230B2 (en) 2014-12-22 2017-04-11 Farmington Pharma Development Creatine prodrugs, compositions and methods of use thereof
AU2018375199B2 (en) 2017-12-01 2023-03-30 Ultragenyx Pharmaceutical Inc. Creatine prodrugs, compositions and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252338A (en) * 1991-06-27 1993-10-12 Alza Corporation Therapy delayed

Also Published As

Publication number Publication date
TW431891B (en) 2001-05-01
EP0821582B1 (en) 2002-12-04
AU5171196A (en) 1996-09-18
JPH11509169A (ja) 1999-08-17
AR003928A1 (es) 1998-09-30
CA2213455A1 (en) 1996-09-06
EP0821582A2 (en) 1998-02-04
MY113429A (en) 2002-02-28
WO1996026718A3 (en) 1996-10-10
DE69625189D1 (de) 2003-01-16
ATE228829T1 (de) 2002-12-15
WO1996026718A2 (en) 1996-09-06
AU722741B2 (en) 2000-08-10

Similar Documents

Publication Publication Date Title
PA8388101A1 (es) Tableta de liberacion controlada.
CA2394672A1 (en) Biodegradable polymer composition
PA8433001A1 (es) Tableta de liberacion controlada
AR054782A2 (es) Composiciones farmaceuticas y tabletas que contienen irbesartan en combinacion con un diuretico
IL119627A0 (en) Controlled-release pharmaceutical preparations
YU14502A (sh) Farmaceutska kombinacija etinilestradiola i drospirenona za primenu kao kontraceptivnog sredstva
PT874642E (pt) Formulacoes de farmacos de libertacao continua
AR002754A1 (es) Composición farmacéutica que comprende bacterias lactobacillus viables micro-encapsuladas, y uso de la composición para preparar de un medicamento
GEP20022851B (en) Flash-Melt Oral Dosage Formulation
HU76547A2 (en) Process for producing pharmaceutical compositions containing agent in polymer-matrix and in solid solution form and these medicaments
GR3036792T3 (en) New bi- and tricyclic aminoalcohol esters, their preparation and their use in medicaments.
AU6136199A (en) Dosage form comprising therapeutic formulation
AU7461796A (en) Insoluble drug delivery
ES2054069T3 (es) Composicion cosmetica o farmaceutica que contiene microesferas de polimeros o de cuerpos grasos cargados de al menos un producto activo.
YU33099A (sh) Farmaceutska smesa za poboljšanje erektilne disfunkcije kod muškaraca
AR011133A1 (es) MICROGRÁNULOS DE LIBERACIoN CONTROLADA QUE CONTIENEN CISPLATINO , PROCEDIMIENTO DE SU PREPARACIoN, COMPOSICIoN FARMACÉUTICA Y UTILIZACIoN EN LA FABRICACIoN DE UN MEDICAMENTO POLIQUIMIOTERAPIA O EN ASOCIACIoN CON UNA RADIOTERAPIA.
MX9801727A (es) Composicion farmaceutica para administracion oral.
DE3884214D1 (de) Verfahren zur herstellung einer festen form mit beibehaltender freisetzung aus einer funktionellen aktiven komposition und die bei dem verfahren erhaltene dosierungsform.
GB0222612D0 (en) Controlled delivery system for bioactive substances
AR025060A1 (es) Formulaciones farmaceuticas en capsulas de hidroxipropilmetilcelulosa
AR003434A1 (es) Compuesto de tiludronato, composiciones farmaceuticas que los contienen y proceso para producir dicho compuesto y procedimiento para producir lascomposiciones farmaceuticas.
ATE173624T1 (de) Synergistische pharmazeutische zusammensetungen, die triamcinolonacetonid und halcinonid enthalten
CA2382426A1 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
AU5784096A (en) Method and composition for prevention of posterior capsule opacification
CO4750645A1 (es) Metodo de preparacion de granulos que incorporan un medica- mento para uso farmaceutico